• The global antiemetics market was valued at $2,251.68 million in 2021, and is projected to reach $4,061.36 million by 2031, registering a CAGR of 6.1% from 2022 to 2031. (researchandmarkets.com)
  • The global microneedle drug delivery systems market size was valued at USD 5.38 billion in 2022 and anticipated to grow at a compound annual growth rate (CAGR) of 7.4% from 2023 to 2030. (grandviewresearch.com)
  • The market value for CNS treatment and therapy was around 57.8% of the overall ~US$ 203.6 Billion of the global antibody therapy market in 2022. (futuremarketinsights.com)
  • As of August 2022[update], it had a market capitalisation of £70 billion, the eighth largest on the London Stock Exchange. (wikipedia.org)
  • The Global Asthma and COPD Drug market is anticipated to rise at a considerable rate during the forecast period, between 2022 and 2031. (menafn.com)
  • Due to the COVID-19 pandemic, the global Asthma and COPD Drug market size is estimated to be worth USD 13270 million in 2022 and is forecast to a readjusted size of USD 15210 million by 2028 with a CAGR of 2.3Percent during the review period. (menafn.com)
  • The global interferons market grew from $8.48 billion in 2022 to $8.82 billion in 2023 at a compound annual growth rate (CAGR) of 4.0% . (thebusinessresearchcompany.com)
  • DUBLIN-( BUSINESS WIRE )-The "Global Dermatology Drugs Market - Forecast 2022 to 2027" report has been added to from ResearchAndMarkets.com offer. (resourcekt.co.uk)
  • Data Bridge Market Research analyses a growth rate in the global geriatric medicines market in the forecast period 2022-2029. (databridgemarketresearch.com)
  • The global contract research and manufacturing services (CRAMS) market size will grow from $120.23 billion in 2022 to $129.97 billion in 2023 at a compound annual growth rate (CAGR) of 8.1% . (thebusinessresearchcompany.com)
  • The purpose of this MRH research study titled "Global Parenteral Drugs Market Insights, Forecast to 2025" is to enlighten the readers about the Parenteral Drugs Market with a stern focus on the development trends and opportunities projected for future years. (express-press-release.net)
  • Future Market Insights, Inc. (futuremarketinsights.com)
  • According to the recent study by Future Market Insights, degenerative diseases are leading the market with an expected share of about 31.7% in the year 2023, within the global market. (futuremarketinsights.com)
  • This is regarding the recent report I bought from Fortune Business insights. (fortunebusinessinsights.com)
  • Are you looking to gain insights into the global medical devices market? (marketresearch.com)
  • Whether you are looking to expand your business, develop new products, or enter new markets, our reports provide you with the insights you need to succeed in a large, dynamic, and highly regulated global industry. (marketresearch.com)
  • It delves deeply into the global market scenario, providing valuable insights into current trends and drivers influencing the Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs Market on a global scale. (digitaljournal.com)
  • Apart from this, the researcher market analyst and experts present their outlook or insights of product sales, market share, and value along with the possible opportunities to grow or tap into in these regions. (pharmiweb.com)
  • Market Research Report Store offers a latest published report on COPD and Asthma Drug Devices Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. (openpr.com)
  • Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. (powershow.com)
  • We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. (powershow.com)
  • This report will save you countless hours of research time while providing valuable insights. (plunkettresearch.com)
  • That's why MarketResearch.com offers a wide range of pharmaceutical reports, providing critical insights into market trends, industry challenges, and emerging opportunities. (marketresearch.com)
  • The global Parenteral Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. (express-press-release.net)
  • As per the report's description, the market size was USD 46.34 billion in 2018 and is likely to exhibit a CAGR of 7.5% between 2019 to 2026. (medgadget.com)
  • The North America Fibromyalgia Treatment Market would witness market growth of 3.7% CAGR during the forecast period (2023-2030). (giiresearch.com)
  • The Canada market is poised to grow at a CAGR of 6.1% during (2023 - 2030). (giiresearch.com)
  • Additionally, The Mexico market would witness a CAGR of 5.1% during (2023 - 2030). (giiresearch.com)
  • The global parkinson's disease drugs market size was valued at USD 4,500.0 Million in 2018, is projected to reach USD 8,383.2 Million by the end of 2026, exhibiting a CAGR of 8.1% during the forecast period. (fortunebusinessinsights.com)
  • The market in Asia Pacific is likely to report the highest CAGR during the forecast duration, attributable to the increasing healthcare spending, improved distribution networks in pharma emerging nations and high demand for China and Japan. (fortunebusinessinsights.com)
  • The global market is expected to enjoy a valuation of US$ 123.2 Billion by the end of the year 2023, and further expand at a CAGR of 5.2% to reach a valuation of ~US$ 205.3 Billion by the year 2033. (futuremarketinsights.com)
  • Thus, owing to the aforementioned factors, the global CNS treatment and therapy market is projected to expand at a CAGR of 5.2% during the forecast period between 2023 and 2033. (futuremarketinsights.com)
  • In 2017, the global Topical Drug Delivery market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. (medgadget.com)
  • The global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs market size was valued at USD 6170.57 million in 2021 and is expected to expand at a CAGR of 4.99% during the forecast period, reaching USD 8264.36 million by 2027. (digitaljournal.com)
  • Asthma and COPD Drug Market Size is projected to Reach Multimillion USD by 2031, In comparison to 2023, at unexpected CAGR during the forecast Period 2023-2031. (menafn.com)
  • Fully considering the economic change by this health crisis, by Type, Bronchodilators accounting for Percent of the Asthma and COPD Drug global market in 2021, is projected to value USD million by 2028, growing at a revised Percent CAGR in the post-COVID-19 period. (menafn.com)
  • While by Application, Asthma was the leading segment, accounting for over percent market share in 2021, and altered to an Percent CAGR throughout this forecast period. (menafn.com)
  • TechNavio's analysts forecast the Generic Drugs market in Japan to grow at a CAGR of 8.16 percent over the period 2014-2019. (clickpress.com)
  • Germany Pharmaceuticals Market size is estimated to reach $61.6 billion by 2026, growing at a CAGR of 6.3% during the forecast period 2021-2026 . (industryarc.com)
  • Data Bridge Market Research analyses the Cancer Nanomedicine Market to grow at a CAGR of 12.50% in the forecast period. (pharmiweb.com)
  • The interferons market is expected to grow from $10.54 billion in 2027 at a CAGR of 4.6% . (thebusinessresearchcompany.com)
  • The global market for emerging medical device technologies should grow from $81.9 billion in 2020 to $146.2 billion by 2025, at compound annual growth rate (CAGR) of 12.3% for the period of 2020-2025. (bccresearch.com)
  • The global market for bariatric devices should increase from $1.5 billion in 2020 to nearly $2.2 billion by 2025 at a compound annual growth rate (CAGR) of 7.5% during the forecast period, 2020-2025. (bccresearch.com)
  • The global market for surgical equipment should grow from $5.0 billion in 2020 to $8.2 billion by 2025, at compound annual growth rate (CAGR) of 10.3% for the period of 2020-2025. (bccresearch.com)
  • The global market for disposable medical sensors should grow from $6.0 billion in 2020 to $9.7 billion by 2025, at a compound annual growth rate (CAGR) of 9.1% for the period of 2020-2025. (bccresearch.com)
  • The global market for in vitro diagnostics (IVD) should increase from $74.1 billion in 2020 to reach $102.4 billion by 2025, at a compound annual growth rate (CAGR) of 6.7% during the period of 2020-2025. (bccresearch.com)
  • The global nanomaterials in personalized medicines market should reach $420.0 billion by 2025 from $253.8 billion in 2020 at a compound annual growth rate (CAGR) of 10.6% for the forecast period of 2020 to 2025. (bccresearch.com)
  • The global ambulance and emergency equipment market should reach $8.9 billion by 2025 from $7.7 billion in 2020 at a compound annual growth rate (CAGR) of 2.9% for the forecast period of 2020 to 2025. (bccresearch.com)
  • The global market for Direct-to-Consumer (DTC) testing should grow from $1.4 billion in 2020 to $2.6 billion by 2025 with a compound annual growth rate (CAGR) of 14.2% for the period of 2020-2025. (bccresearch.com)
  • The global market for home health monitoring systems should grow from $12.3 billion in 2020 to reach $29.1 billion by 2025, at a compound annual growth rate (CAGR) of 18.8% during the period of 2020-2025. (bccresearch.com)
  • According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by 2021, growing at a CAGR of around 10.8 % between 2016 and 2021. (globenewswire.com)
  • The global dermatology drugs market is expected to grow at a CAGR of 11.22% over the forecast period to reach US$47.892 billion by 2027, from US$22.747 billion in 2020. (resourcekt.co.uk)
  • The global COPD and Asthma Drug Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. (openpr.com)
  • The research report defines USD values, CAGR (compound annual growth rate) values and their variations for the precise projected time frame. (marketresearchupdate.com)
  • The global nanopharmaceutical drugs market size was USD 53.85 Billion in 2021 and is expected to register a revenue CAGR of 7.4% during the forecast period. (emergenresearch.com)
  • The anti-obesity drugs market is expected to register a CAGR of 15% over the forecast period. (mordorintelligence.com)
  • The expected CAGR of global geriatric medicines market is tend to be around 6.50% in the mentioned forecast period. (databridgemarketresearch.com)
  • The principle motivation behind this report is to give a development map with respect to the activities taken by central participants of the IBS-C Drugs market like item dispatches, joint endeavors, propensities, consolidations, and acquisitions which is influencing the IBS-C Drugs market and Life & Medical undertaking in general and furthermore influencing the business, import, fare, income and CAGR values. (marketresearchupdate.com)
  • Each regional and country-wise Global Myasthenia Gravis Disease Drugs market considered for research and analysis has been thoroughly studied based on market share, future growth potential, CAGR, market size, and other important parameters. (stockmarketmonster.com)
  • The market size of the contract research and manufacturing services (CRAMS) is expected to grow to $183.81 billion in 2027 at a CAGR of 9.1% . (thebusinessresearchcompany.com)
  • This report studies the global market size of Parenteral Drugs in key regions like North America, Europe, China and Japan, focuses on the consumption of Parenteral Drugs in these regions. (express-press-release.net)
  • The Robotic Pharmacy Prescription Dispensing Systems Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. (openpr.com)
  • Geographically, the global nasal drug delivery devices market is categorized into North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa. (medgadget.com)
  • However, improved R&D spending and expected approval and launch of potential pipeline drug candidates is estimated to render the maximum Parkinson's disease drugs market share to North America at the end of 2026. (fortunebusinessinsights.com)
  • Furthermore, the launch of INBRIJA, an inhalation powder to treat patients with Parkinson's disease by Acorda Therapeutics in the U.S. in February 2019 is anticipated to accelerate the Parkinson's disease drugs market growth in North America. (fortunebusinessinsights.com)
  • The report presents the current conditions and potential opportunities in the Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs market across regions like North America, Asia Pacific, Europe, Latin America, the Middle East, and Africa. (digitaljournal.com)
  • In addition the report encompasses global Cancer Nanomedicine market segmentation on the basis of diverse facets like product/service type, application, technology, end-users, and major geographic regions North America, Europe, Asia-Pacific and Latin America. (pharmiweb.com)
  • Based on the geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa. (globenewswire.com)
  • During the forecast period, North America and the Asia-Pacific region are expected to hold a major share of the global market . (resourcekt.co.uk)
  • Due to the sheer availability of dermatology drugs, North America is estimated to account for a large portion of the dermatology drugs market during the forecast period. (resourcekt.co.uk)
  • This report studies the global market size of Retail Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Retail Drug in these regions. (marketresearchupdate.com)
  • Within North America, US is anticipated to hold the 90% of the market share. (ipsnews.net)
  • The Report Covers Global Anti Obesity Drugs Market Size & Statistics and it is Segmented by Mechanism of Action (Peripherally Acting Drugs and Centrally Acting Drugs), Drug Type (Prescription Drugs and OTC Drugs), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). (mordorintelligence.com)
  • Thus, it is anticipated that a high prevalence of cancer cases and extensive use of chemotherapy as the treatment option will fuel the global antiemetics market during the forecast period. (researchandmarkets.com)
  • This is further expected to drive the overall market in the forecast period. (medgadget.com)
  • Moreover, biopharma companies are utilizing novel technologies for introducing MDI and DPI into the regional market for higher revenue generation during the forecast period. (medgadget.com)
  • The segment is estimated to lead market during the forecast period. (fortunebusinessinsights.com)
  • Increased government funding to accelerate the clinical development of newly discovered drugs is expected to fuel the rapid growth of the central nervous system therapeutics market during the forecast period. (futuremarketinsights.com)
  • Surging volume of patients suffering from cancer, and other chronic disorders, increasing number of geriatric population across the globe, increasing development of nanotechnology-based drugs as well as therapies, adoption of advanced technologies are some of the factors which will likely to enhance the growth of the cancer nanomedicine market in the forecast period of 2020-2027. (pharmiweb.com)
  • On the other hand, surging levels of investment on research and development activities along with introduction of advanced diagnostics procedure which will further bring immense opportunities for the growth of the cancer nanomedicine market in the above mentioned forecast period. (pharmiweb.com)
  • Low rate of adoption along with increasing side effects associated with the consumption of nanoparticles, stringent regulatory framework for approvals of drugs are acting as market restraints for the growth of the cancer nanomedicine market in the above mentioned forecast period. (pharmiweb.com)
  • However, an untapped and emerging market like India and China are expected to generate more opportunities for generic drug market in the forecast period. (globenewswire.com)
  • This may result in new treatment options, boosting market growth over the forecast period. (mordorintelligence.com)
  • Hence, the increasing obese population, rise in unhealthy eating habits, and sedentary lifestyles are expected to drive the market growth over the forecast period. (mordorintelligence.com)
  • During the forecast period, the market for geriatric medications is anticipated to expand significantly. (databridgemarketresearch.com)
  • As a result, the growing elderly population is driving the growth of the global geriatric medicines market during the forecast period. (databridgemarketresearch.com)
  • This market study helps to expand the current product portfolio and market presence during the forecast period. (newstechzone.com)
  • The forecast period 2021-2026 is expected to be great for the IBS-C Drugs market which will be the face changer for the Life & Medical industry. (marketresearchupdate.com)
  • We also provide an analysis of the current trends and drivers of the market in the forecast period. (stockmarketmonster.com)
  • The rising ageing population with various chronic diseases is expected to have a positive impact on the growth of the contract research and manufacturing services (CRAMS) market in the forecast period. (thebusinessresearchcompany.com)
  • thereby, achieving a market value of $1,022.1 million by 2030. (giiresearch.com)
  • The diagnosis report for other nervous system disorder diseases have also increased significantly in the recent past and is estimated to reach 82 million by 2030. (futuremarketinsights.com)
  • Moreover, the Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs Market Report explores potential drivers for development and examines the current market share distribution and adoption of various types, technologies, applications, and regions up to 2030. (digitaljournal.com)
  • The Retail Drug is projected to rise moderately in the projected time frame of 2023-2030. (marketresearchupdate.com)
  • By 2030, we anticipate net, annual cost savings of over USD 23 billion to be brought about by the adoption of in silico tools in large molecule drug discovery processes. (ipsnews.net)
  • Clinical Trial Kits Market: By Size, Share, Growth, Segments, Analysis and Forecast, 2030 , a new study from Polaris Market Research, provides a detailed overview of the market, including a critical analysis of the current situation of the Market. (newstechzone.com)
  • The worldwide Clinical Trial Kits Market insightful report efficiently evaluates the current market size and provides an industry forecast till 2030. (newstechzone.com)
  • Florida, January 16, 2018: Drug screening is used for distinguishing supported and furthermore unlawful prescriptions in blood, urine, and other biological samples generally at hospitals, trained athletes, places of employment, schools and post-mishap. (openpr.com)
  • Florida, January 16, 2018: Fetal Bovine Serum is a critical raw material for several research areas, animal health, biotechnology and pharmaceutical industry. (openpr.com)
  • Florida, January 16, 2018: The Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market is segmented on the lines of its technology, treatment, application and regional. (openpr.com)
  • Florida, January 16, 2018: The Robotic Pharmacy Prescription Dispensing Systems Market is segmented on the lines of its end user and regional. (openpr.com)
  • Among these, Europe is holding the largest share with a nasal drug delivery technology market revenue of USD 21.1 billion in 2018. (medgadget.com)
  • For instance, in October 2018, Pfizer Inc., one of the prominent pharmaceutical companies partnered with Bain Capital to launch a biopharmaceutical company for developing drugs for Parkinson's and other conditions of the central nervous system named Cerevel Therapeutics, further boosting the Parkinson's disease drugs market growth. (fortunebusinessinsights.com)
  • Decarboxylase inhibitors, which consist of carbidopa and levodopa dominated the market with a share of 37.8% in 2018. (fortunebusinessinsights.com)
  • In 2018, the oral segment accounted for maximum share in Parkinson's disease drugs market owing to the active government recommendations and more preference for oral drugs. (fortunebusinessinsights.com)
  • Europe leads the global Parkinson's disease market with maximum revenue of USD 1,540.7 Mn in 2018, owing to the increasing prevalence of Parkinson's disease, active government support through government aided pharmacies. (fortunebusinessinsights.com)
  • Hoffmann-La Roche Ltd and UCB S.A have emerged as a leading player in the market owing to the higher sales of Madopar and Neupro in 2018. (fortunebusinessinsights.com)
  • The report projects the Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs market's value and sales volume for the period between 2018 and 2028. (digitaljournal.com)
  • The report assesses the value and sales volume of the Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs market, categorized by type and application, from 2018 to 2028. (digitaljournal.com)
  • New York, NY, March 21, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled "Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021" . (globenewswire.com)
  • A Kaiser Family Foundation analysis of drug pricing data from 2014-2018 showed the price of some medicines, particularly brand name and specialty drugs, rose on average, while prices of generic products generally declined. (ncsl.org)
  • This study also provides the scope of different segments and applications that can potentially influence the industry in the future. (digitaljournal.com)
  • The Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs Share report provides an overview of market value structure, cost drivers, and various driving factors and analyzes the industry atmosphere, then studies the global outline of industry size, demand, application, revenue, product, region, and segments. (digitaljournal.com)
  • The Generic Drugs market in Japan can be divided into three segments: Generic Prescription Medicines, Super Generics, and Biosimilars. (clickpress.com)
  • Different recovery scenarios are also included in the report for all the segments and regions/nation. (einpresswire.com)
  • CNS and Cardiovascular segments are the two largest market segment covered by generic drug market. (globenewswire.com)
  • This study mainly helps understand which market segments or Region or Country they should focus in coming years to channelize their efforts and investments to maximize growth and profitability. (openpr.com)
  • The report also involves the structure of the industry by identifying its several sub-segments. (marketresearchupdate.com)
  • How is the current and future market opportunity likely to be distributed across key market segments? (ipsnews.net)
  • The market size and forecasts are provided in terms of value (USD million) for the above segments. (mordorintelligence.com)
  • The report covers crucial information about the Clinical Trial Kits Market by dividing it into different segments for better understanding. (newstechzone.com)
  • This section of the report furnishes details regarding the major revenue-generating, major shareholder, and dominating segments that are a major booster for the growth of the Clinical Trial Kits Market. (newstechzone.com)
  • The segmental analysis section of the report includes a thorough research study on key type and application segments of the Global Global Myasthenia Gravis Disease Drugs market. (stockmarketmonster.com)
  • All of the segments considered for the study are analyzed in quite some detail on the basis of market share, growth rate, recent developments, technology, and other critical factors. (stockmarketmonster.com)
  • The segmental analysis provided in the report will help players to identify high-growth segments of the Global Global Myasthenia Gravis Disease Drugs market and clearly understand their growth journey. (stockmarketmonster.com)
  • Global Nasal Drug Delivery Devices Market trends, with detailed analysis on consumer trends & manufacturer trends. (medgadget.com)
  • Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors. (medgadget.com)
  • Our reports provide you with comprehensive market data-including market size, market share, growth rates, and forecasts-compiled by industry experts who have a deep understanding of the market and its trends. (marketresearch.com)
  • Our research features detailed analysis of the competitive landscape, including market leaders and emerging players, as well as expert commentary on industry trends, market drivers, and challenges. (marketresearch.com)
  • This report offers a comprehensive analysis of the Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs Market, encompassing its present condition, key players in the industry, emerging trends, and prospects for future growth. (digitaljournal.com)
  • The report examines trends, prospects, challenges, and risks impacting the Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs market. (digitaljournal.com)
  • Browse Detailed TOC of Asthma and COPD Drug Market report with 133 Tables and Figures andCharts that provides exclusive data, information, vital statistics, trends, and competitive landscape details in this niche sector. (menafn.com)
  • The Asthma and COPD Drug Market evaluation provides information on the major business trends that will impact the market's growth between 2023 and 2031. (menafn.com)
  • Cancer Nanomedicine Market to Build Excessive Revenue at Healthy Growth rate at 12.50% up to 2027 - Industry Share, Size, Trends, Top Key Players-Arrowhead Pharmaceuticals, AstraZeneca, Cadila Pharmaceuticals. (pharmiweb.com)
  • The study conducted for Cancer Nanomedicine industry also analyses the market status, size, share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors with the help of SWOT analysis and Porter's Five Forces Analysis. (pharmiweb.com)
  • To strategically analyze micro-markets with respect to individual growth trends, future prospects, and contribution to the total market, covered by Global COPD and Asthma Drug Devices Market and various regions. (openpr.com)
  • The Market Research Update provide detailed report study and highlights market share and size, and regional changing trends, production value predication, new prospects for Retail Drug market development rate. (marketresearchupdate.com)
  • To observe the industry with reverence to individual future prospects, development trends, and contribution to the overall market. (marketresearchupdate.com)
  • Below, I republish the section highlighting five significant industry trends affecting the U.S. drug wholesaling industry. (drugchannels.net)
  • Here are five significant industry trends that will substantially impact the drug wholesaling industry in the coming years. (drugchannels.net)
  • We also cover disruptive trends, such as gene editing, precision medicine, and artificial intelligence, ensuring our clients stay ahead of market changes. (marketresearch.com)
  • The report further provides a detailed segmentation of the Myasthenia Gravis Disease Drugs market, giving an analysis of the current trends and drivers of the market. (stockmarketmonster.com)
  • Taking this into consideration, the analysts authoring the report have provided an exhaustive analysis of specific trends of each regional Global Myasthenia Gravis Disease Drugs market. (stockmarketmonster.com)
  • This report covers the present scenario and the growth prospects of the Generic Drugs market in Japan for the period 2015-2019. (clickpress.com)
  • TechNavio's report, the Generic Drugs market in Japan 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. (clickpress.com)
  • What will the market size be in 2019 and what will the growth rate be? (clickpress.com)
  • According to the Medicaid and CHIP Payment and Access Commission, gross spending in the U.S. for prescription drugs in Medicaid totaled $66.7 billion in 2019 and, on average, states spend between 4-5% of their Medicaid budget on prescription drugs. (ncsl.org)
  • DelveInsight's pharmaceuticals report, "Concerta Drug Insight, 2019" highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. (valuates.com)
  • The report covers the Global Market Assessment of the Concerta covering the historical global sales and also provides the Concerta sales estimation during the forecasted period (2019-2021). (valuates.com)
  • Winton Gibbons, a pharmaceutical industry analyst at William Blair & Co. in Chicago, said prescriptions for impotence drugs had grown 15% in the last 18 months, despite the introduction in 2003 of Bayer's Levitra and Eli Lilly & Co.'s Cialis to compete with Viagra. (latimes.com)
  • Furthermore, nanopharmaceutical drugs are highly target-specific and have revolutionized the pharmaceutical industry. (emergenresearch.com)
  • The global pharmaceutical industry is a vital part of the healthcare landscape-it is an industry that affects everyone, from patients seeking treatment to healthcare providers looking for the latest advances in medicine. (marketresearch.com)
  • The purpose of this meeting, the third in a series of four, was to elicit the views of health care providers, representatives of the pharmaceutical industry, and consumers regarding the impact of managed care reimbursement policies on translational research, which takes new therapies from the bench to the bedside. (nih.gov)
  • In addition, it appears that in some areas of the country, the pharmaceutical industry is assuming an increasing portion of clinical trial costs in order to bring promising new therapies to the market quickly. (nih.gov)
  • Despite all the efforts by the Ministry of Health to provide adequate and safe medicines, the Iraqi pharmaceuti- cal sector has several challenges, including inadequate budget allocated to the ministry, shortages in essential medicines, underutilization of electronic technologies in the management of regulation-related work, a large number of substandard and falsified medications in the private sector and a stagnant national pharmaceutical industry. (who.int)
  • Attended by close to 200 representatives of regulatory authorities and the pharmaceutical industry as well as clinical pharmacologists, the conference aimed to identify the strengths and weaknesses of existing mechanisms for international cooperation and to propose improvements for the future. (who.int)
  • Based on end user segmentation it covers hospital pharmacies and retail pharmacies. (openpr.com)
  • This report focuses on global and United States Asthma and COPD Drug market, also covers the segmentation data of other regions in regional level and county level. (menafn.com)
  • Market segmentation by type, application, and other factors. (newstechzone.com)
  • The global " Nasal Drug Delivery Devices Market Size " is prognosticated to reach USD 81.85 billion by 2026 attributable to the increasing number of the patient population and the rising prevalence of pulmonary disorders worldwide. (medgadget.com)
  • The rise in focus on developing advanced Bronchodilators to meet the growing demand from asthma patients in the country, increase in awareness about the benefits of immunosuppressant, rise in the demand for Camostat mesylate inhibitors, and the growing investment by the key players to develop advanced pharmaceutical products are the factors that are set to drive the growth of the Germany Pharmaceuticals Market for the period 2021-2026. (industryarc.com)
  • This research report categorizes the global Parenteral Drugs market by top players/brands, region, type and end user. (express-press-release.net)
  • The global antiemetics market is segmented on the basis of drug type, application, distribution channel, and region. (researchandmarkets.com)
  • Moreover, the increased clinical studies and successful launch of products such as RYTARY by Impax Laboratories, Inc. is expected to accelerate the demand for decarboxylase inhibitors in the forecast duration, which will, in, turn contribute to the global Parkinson's disease drugs market growth. (fortunebusinessinsights.com)
  • Orbis Research Market brilliance released a new research report of 108 pages on title 'Global Topical Drug Delivery Market' with detailed analysis, forecast and strategies. (medgadget.com)
  • This report focuses on the global Topical Drug Delivery status, future forecast, growth opportunity, key market and key players. (medgadget.com)
  • To analyze global Topical Drug Delivery status, future forecast, growth opportunity, key market and key players. (medgadget.com)
  • The global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs size is segmented on the basis of application, end user, and region, with a focus on manufacturers in different regions. (digitaljournal.com)
  • The effects of significant events like the Russia-Ukraine war and global inflation rates on the Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs market are analyzed. (digitaljournal.com)
  • By 1999, Glaxo Wellcome had become the world's third-largest pharmaceutical company by revenues (behind Novartis and Merck), with a global market share of around 4 per cent. (wikipedia.org)
  • The knowledge provided forecasts for the potential future growth in important markets and significant players on the global market. (menafn.com)
  • With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth. (menafn.com)
  • The Cancer Nanomedicine Market report encompasses the general idea of the global Cancer Nanomedicine market including definition, classifications, and applications. (pharmiweb.com)
  • According to this report Global Cancer Nanomedicine Market will rise from Covid-19 crisis at moderate growth rate during 2020 to 2027. (pharmiweb.com)
  • Top companies (Shionogi & Co., Ltd., Pfizer, Inc., & Merck & Co., Inc.) constitute more than XX% share of the global Dyslipidemia Drugs market . (einpresswire.com)
  • The global interferon drugs market is projected to grow at a rapid pace in the next few years due to the increasing incidence of chronic diseases such as hepatitis-B, hepatitis-C, cancer, and multiple sclerosis, the use of interferons in combinational therapies, and the advent of novel drug delivery systems. (thebusinessresearchcompany.com)
  • The cardiovascular segment covers more than 20% of global generic drug market due to a number of patent expiry of cardiovascular drugs. (globenewswire.com)
  • The global dermatology drugs market is segmented by indication, route of administration, end user and geography. (resourcekt.co.uk)
  • The global dermatology pharmaceuticals market is likely to be further impacted by the regular release of new customer-centric products. (resourcekt.co.uk)
  • Global COPD and Asthma Drug Devices Market is accessible to readers in a logical, wise format. (openpr.com)
  • This intelligence report provides a comprehensive analysis of the "Global COPD and Asthma Drug Devices Market. (openpr.com)
  • To Define, Describe, and Segment The Global COPD and Asthma Drug Devices Market On The Basis Of Type, Function, Application, And Region. (openpr.com)
  • To estimate the size of the Global COPD and Asthma Drug Devices Market in terms of value. (openpr.com)
  • To track and analyze competitive developments such as joint ventures, mergers & acquisitions, and new product launches, in Global COPD and Asthma Drug Devices Market. (openpr.com)
  • What are the top companies at intervals in the global Retail Drug market? (marketresearchupdate.com)
  • What are the growth strategies of the key players to sustain hold at intervals in the global Retail Drug market? (marketresearchupdate.com)
  • Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. (powershow.com)
  • Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits. (powershow.com)
  • We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. (powershow.com)
  • A rapidly multiplying geriatric population increasing prevalence of chronic ailments such as cancer and cardiac disease growing awareness among patients and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. (powershow.com)
  • Market Study by Global Industry Analysts, Inc. (strategyr.com)
  • Furthermore, growing number of global funding generate an increased possibility of development of nano-formulations with enhanced efficacy, Drug Dose Response (DRC), and bioavailability. (emergenresearch.com)
  • Based on type, the global nanopharmaceutical drugs market is segmented into therapeutics, regenerative medicine, and diagnostics. (emergenresearch.com)
  • The therapeutics segment accounted for largest revenue share in the global Nanopharmaceutical drugs market in 2021. (emergenresearch.com)
  • This report throws light on the competitive scenario of the Clinical Trial Kits Market to know competition at the national and global levels. (newstechzone.com)
  • A new research report on the Global IBS-C Drugs Market titled has recently published by Market Research Update to its humongous database which helps to shape the future of the businesses by making well-informed business decisions. (marketresearchupdate.com)
  • What are the major challenges in front of the global IBS-C Drugs market? (marketresearchupdate.com)
  • Who are the key vendors of the global IBS-C Drugs market? (marketresearchupdate.com)
  • Moreover, it will help them to identify key growth pockets of the Global Global Myasthenia Gravis Disease Drugs market. (stockmarketmonster.com)
  • The geographical analysis of the Global Global Myasthenia Gravis Disease Drugs market provided in the report is just the right tool that competitors can use to discover untapped sales and business expansion opportunities in different regions and countries. (stockmarketmonster.com)
  • B) The report provides Global Myasthenia Gravis Disease Drugs market revenues at the worldwide, regional, and country levels with a complete analysis to 2028 permitting companies to analyze their market share and analyze projections, and find new markets to aim for. (stockmarketmonster.com)
  • C) The research includes the Global Myasthenia Gravis Disease Drugs market split by different types, applications, technologies, and end-uses. (stockmarketmonster.com)
  • D) Global Myasthenia Gravis Disease Drugs market analysis benefits investors by knowing the scope and position of the market giving them information on key drivers, challenges, restraints, and expansion chances of the market and moderate threats. (stockmarketmonster.com)
  • Global Markets Direct's, 'Nausea - Pipeline Review, H2 2015', provides an overview of the Nausea's therapeutic pipeline. (prnewswire.com)
  • Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. (prnewswire.com)
  • The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. (prnewswire.com)
  • Acadia Pharmaceuticals Inc. is ranked third in the Parkinson's Disease drugs market due to the higher demand for Nuplazid. (fortunebusinessinsights.com)
  • Pharmaceuticals are drugs used in the diagnosis, treatment, and prevention of the diseases. (industryarc.com)
  • However, the high cost of raw materials used in the production of pharmaceuticals is one of the major factors that is said to reduce the growth of the Germany Pharmaceuticals Market. (industryarc.com)
  • The rise in investments by the key players in the country to develop advanced immunosuppressants and the increasing focus on developing advanced Bronchodilators to meet the growing demand from asthma patients in the country are the major factors driving the growth of the Germany Pharmaceuticals Market. (industryarc.com)
  • Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Germany Pharmaceuticals Market report. (industryarc.com)
  • The growing commercialization of novel drugs for treating various cancers in the country is driving the growth of the Germany Pharmaceuticals Market. (industryarc.com)
  • Germany Pharmaceuticals Market based on the Application can be further segmented into Oncology, Infectious Diseases, Central Nervous System Disorders, Cardiovascular Diseases, and Others. (industryarc.com)
  • The growing demand for Bronchodilator drug types is driving the growth of the Germany Pharmaceuticals Market. (industryarc.com)
  • The key players across the world are focusing on developing advanced Bronchodilators to meet the growing demand from asthma patients in the country, which is one of the major factors driving the growth of the Germany Pharmaceuticals Market. (industryarc.com)
  • In short, this assessment drops light on the market size and revenue share which are motivated by numerous market drivers, together with a clear insight about challenges that might create a blockage for the development of Parenteral Drugs Market . (express-press-release.net)
  • The objectives of this study are to define, segment, and project the size of the Parenteral Drugs market based on company, product type, end user and key regions. (express-press-release.net)
  • I don't think Medicare coverage is going to add much to the market size or much to Medicare costs," Gibbons said, because men between the ages of 40 and 60 make up the prime market for the drugs -- a group too young to qualify for the federal health insurance program for the elderly and disabled. (latimes.com)
  • The implementation of new technologies and innovative solutions will drive the market's revenue generation and increase its market share by 2028 with Revenue by Type ( Angiogenesis Inhibitors, mTOR Inhibitors, Monoclonal Antibodies, Cytokine Immunotherapy (IL-2) ), Forecasted Market Size by Application ( Renal cell carcinoma (RCC), Transitional cell carcinoma (TCC), Others ). (digitaljournal.com)
  • In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. (powershow.com)
  • New Jersey, United States,- Our report on the Myasthenia Gravis Disease Drugs market provides an in-depth analysis of the market size, growth rate, and competitive landscape. (stockmarketmonster.com)
  • The market research report covers the analysis of key stake holders of the market. (giiresearch.com)
  • Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. (fortunebusinessinsights.com)
  • Each segment and sub-segment is analyzed in the research report. (openpr.com)
  • Market Research Report Store (MRRS) is a professional organization related to market research reports in all directions .To provide customers with a variety of market research reports, MRRS cooperates with a large of famous market report publishers all over the world. (openpr.com)
  • The Amyotrophic Lateral Sclerosis pipeline drugs market research report provides comprehensive information on the therapeutics under development for Amyotrophic Lateral Sclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. (globaldata.com)
  • Report comprised of the market companies, to describe and define and analyze the Retail Drug market value, share competition landscape, development plans and SWOT analysis. (marketresearchupdate.com)
  • The report also comprises a several market dynamics. (marketresearchupdate.com)
  • The reports are designed to qualitatively explain market dynamics showed in the database. (klinegroup.com)
  • Our report is supplemented by a comprehensive overview of the Myasthenia Gravis Disease Drugs industry, which includes market dynamics, industry growth, opportunities, and barriers. (stockmarketmonster.com)
  • The growth of CNS therapeutics for the soaring cases of mental illness and central nervous system disorders associated with faulty lifestyle is providing the necessary impetus for the establishment and growth of the CNS treatment and therapy market across the geographical regions. (futuremarketinsights.com)
  • In 2020, Esperion therapeutics has US Food and Drug Administration has received approval bempedoic acid (Nexletol) which is a non-statin LDL cholesterol (LDL-C)-lowering medicine and can be administered an orally, once-daily, for the treatment of established atherosclerotic cardiovascular disease (ASCVD) who require additional lowering of LDL-C or treatment of adults with heterozygous familial hypercholesterolemia (HeFH). (einpresswire.com)
  • The therapeutics segment consists of nanopharmaceutical drugs and nanopharmaceutical devices. (emergenresearch.com)
  • The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. (globaldata.com)
  • Some of the leading players in the Amyotrophic Lateral Sclerosis pipeline drugs market are Biogen Inc, 1st Bio Therapeutics Inc, AcuraStem Inc, Denali Therapeutics Inc, Mitsubishi Tanabe Pharma Corp, Orpheris Inc, ProMIS Neurosciences Inc, PurMinds NeuroPharma Inc, QurAlis Corporation, and Treeway BV. (globaldata.com)
  • This report provides comprehensive information on the therapeutic development for Nausea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. (prnewswire.com)
  • Parenteral drugs, whether a small-molecule or biologic-based drug substance, has increased their share of the overall drug market although solid-dosage products still prevail. (express-press-release.net)
  • Apart from this, Asia Pacific market share is likely to attract significant nasal drug delivery devices market share owing to the rise in awareness campaigns about the use of inhalers and its benefits. (medgadget.com)
  • We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. (fortunebusinessinsights.com)
  • The Oncology segment held the largest share in 2020 owing to the factors such as the growing focus on developing new drugs to enhance the availability of prescription drugs and the rise in product launches by the key players. (industryarc.com)
  • Latest analysis highlights high growth emerging players and leaders by market share that are currently attracting exceptional attention. (pharmiweb.com)
  • Pure generic drugs segment is dominating the market with high market share. (globenewswire.com)
  • Data True to market on the products, strategies and market share of leading companies of this particular market are mentioned. (openpr.com)
  • Increasing industry share of Asian economies in world trade and rapid industrialization in emerging economies are expected to boost demand in this region. (marketresearchupdate.com)
  • By drug type, the prescription drug segment is expected to hold a significant market share. (mordorintelligence.com)
  • The law required health officials to share with the attorney general's office price information about generic drugs. (healthcareforall.com)
  • The cost of drugs, vaccines, and other medications are excluded from the report's scope. (marketresearch.com)
  • Additionally, the report offers detailed information about the position, growth scope, and opportunities of new entrants or players in the market. (newstechzone.com)
  • We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. (medgadget.com)
  • Many businesses and enterprises in various industry verticals have started implementing corporate wellness programs for their employees. (bccresearch.com)
  • This can reduce the amount of drugs needed to achieve therapeutic effects, potentially reducing healthcare costs and minimizing side effects. (grandviewresearch.com)
  • New research activities conducted in the sphere of mental health and psychiatric disorders have increased the demand for treatment and therapeutic opportunities available in the CNS treatment and therapy market. (futuremarketinsights.com)
  • The guidance notes that if benzene use is unavoidable to produce a drug product with a significant therapeutic advance, then its levels should be restricted to 2 parts per million (ppm), unless otherwise justified. (fda.gov)
  • This is because of the ongoing trials on various drug candidates including interferons as potential therapeutic options for COVID-19 treatment. (thebusinessresearchcompany.com)
  • Majority of deaths due to chronic diseases are attributed to lack of precision in treatment procedures and accurate drug delivery mechanism of therapeutic candidates generally used. (emergenresearch.com)
  • Drugs, such as stavudine and abacavir, possess a very low half-life, which affects patient's therapeutic regimen significantly. (emergenresearch.com)
  • Additionally, the report provides an overview of key players involved in therapeutic development for Amyotrophic Lateral Sclerosis and features dormant and discontinued projects. (globaldata.com)
  • Additionally, the occurrence of gastroenteritis, often known as stomach flu, contributes to market growth. (researchandmarkets.com)
  • Additionally, the increasing prevalence of asthma and chronic obstructive pulmonary disease (COPD) cases is also aiding to the expansion of the market for pulmonary drug delivery devices. (medgadget.com)
  • Additionally, the increase in the occurrence of skin conditions such as dermatitis, acne, and psoriasis is a major factor driving the boom in this market. (resourcekt.co.uk)
  • The Centers for Disease Control and Prevention (CDC) reports that in the U.S., approximately 34.2 million people, or 10.5% of the population, have diabetes. (grandviewresearch.com)
  • In fact, a survey by the Centers for Disease Control and Prevention showed 1 in 3 Americans report taking at least one medicine annually with an estimated 19.1% of adults between the ages 45 to 64 taking five or more. (ncsl.org)
  • Owing to increasing competition frequent innovations are taking place in the market. (medgadget.com)
  • Medicare is counting on competition among the private drug plans to keep prices in check for all drugs. (latimes.com)
  • The administration's aggressive push to approve more generics is designed to spur more competition with expensive brand-name drugs, and drive prices lower, President Donald Trump noted at a White House event last month. (californiahealthline.org)
  • Generics sellers have fought for years against patent litigation and other delay tactics that protect brand-name drugs from competition. (californiahealthline.org)
  • In addition, this report introduces the market competition situation among the distributors and manufacturers profile, market value analysis, and cost chain structure are covered in this report. (digitaljournal.com)
  • However, high competition and the shortage of drugs can restrict the growth of generic drug market. (globenewswire.com)
  • Increase state oversight of market competition. (ncsl.org)
  • The organization has argued that the measure could hurt competition by scaring companies out of the business of making generic drugs and actually drive up prices. (healthcareforall.com)
  • As AAM has always maintained, this law, and any others modeled from it, would harm patients because the law would reduce generic drug competition and choice, thus resulting in an overall increase in drug costs due to increased reliance upon more-costly branded medications," Davis said in a statement. (healthcareforall.com)
  • The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. (valuates.com)
  • E) This report would help to understand competition better with a detailed analysis and key strategies of their competitors and plan their position in the business. (stockmarketmonster.com)
  • The drug regulators including the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority (HRA) have approved the initiation of trials evaluating interferons. (thebusinessresearchcompany.com)
  • Further, research conducted by GoodRx reports since 2014, the price of brand name medicines increased by 33%, more than a majority of other health care goods and services, including both hospital and physician services. (ncsl.org)
  • A federal appeals court ruled Friday that a Maryland law passed last year to stop sharp increases in the price of generic medicines is unconstitutional, a setback to new efforts by states to keep down the cost of drugs. (healthcareforall.com)
  • Maryland passed the legislation after reports of steep price increases for generic drugs - those no longer covered by a patent - especially those where a small number of companies controlled the market for medicines doctors deem essential. (healthcareforall.com)
  • But the Association for Accessible Medicines, a drug industry trade group, sued the state over the law, saying it was unconstitutional. (healthcareforall.com)
  • the compounding pharmacy market as many people with chronic conditions faced difficulties obtaining their medicines due to closed medical offices and imposed government lockdown in several countries. (marketresearch.com)
  • The expansion of this market can be attributed to emerging markets and significant investments in R&D. The growth of geriatric medicines market is enhanced by the growing cases of orthopedics diseases such as osteoporosis and arthritis, the vulnerable aging population and the rise in research and development activities conducted by many pharmaceutical companies. (databridgemarketresearch.com)
  • With the increase in the geriatric population, the prevalence of various diseases like cancer, diabetes, Alzheimer's, arthritis, and other diseases will also rise, and the demand for various drugs or medicines will increase. (thebusinessresearchcompany.com)
  • All health care providers working in Iraq: approving medicines/vaccines, issuing marketing the public health sector are government employees. (who.int)
  • The Directorate pharmaceutical products by the Iraqi Ministry of Health regulates the following health products: medicines, from registration and approval to post-marketing, assess biotherapeutics, vaccines, blood and blood components, the main challenges faced and make recommendations herbal and traditional medicines, food supplements, to tackle the issues. (who.int)
  • Different factors, for example, downstream purchasers, Supply chain, and sourcing methodology have been evaluated to give a total and top to bottom perspective on the market. (marketresearchupdate.com)
  • The Food and Drug Administration has approved more than 1,600 generic drug applications since January 2017 - about a third more than it did in the last two years of the Obama administration. (californiahealthline.org)
  • I think Drug Channels readers will enjoy this summary as we look toward an eventful 2017. (drugchannels.net)
  • The sales, pricing, revenue, gross margin, product portfolio, and applications of the top 10-15 players in the Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs market are reviewed. (digitaljournal.com)
  • On the contrary, rise in research and development activities by key market players and increase in healthcare expenditure has further encouraged many key players to enter emerging markets, thus offering lucrative opportunities for the expansion of the antiemetics market. (researchandmarkets.com)
  • The main growth drivers for the market are the increasing prevalence of dermatological conditions and the boom in healthcare research and development. (resourcekt.co.uk)
  • Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets. (powershow.com)
  • Outpatient prescription drug spending is projected to grow along with overall national healthcare expenditures. (drugchannels.net)
  • These key strategies are mainly adopted by the key market players to expand their business and their product portfolio, which leads to increase in sales of the company, along with the growth of the market. (researchandmarkets.com)
  • Comprehensive company profiles of the major industry players. (medgadget.com)
  • Also, the strategic collaboration of UCB S.A for the distribution of Parkinson's disease drugs enabled the company to hold a major portion of the market. (fortunebusinessinsights.com)
  • It was the largest health-care fraud case to date in the US and the largest settlement by a drug company. (wikipedia.org)
  • The drug is the first orally administrable non-statin, LDL-lowering medication approved since 2002, Through this development company will widen revenue generation from a market-focused product portfolio. (einpresswire.com)
  • Branded generic drugs are bioequivalent to the generic drugs, but the difference is they are marketed under another company brand names. (globenewswire.com)
  • Our research offers valuable information on the market landscape, key factors driving change, company and product profiles, and regulatory analysis. (marketresearch.com)
  • For over 20 years, we have been a leading company in the field of market research, bringing together reports from hundreds of leading firms in one place for convenient access. (marketresearch.com)
  • Drug companies and company officials gave at least $17 million to federal candidates in the 2004 election. (psychrights.org)
  • This factor will, in, turn benefit the market revenue. (fortunebusinessinsights.com)
  • The report also includes statistical data on revenue growth in various regional and country-level markets, as well as an assessment of the competitive landscape and detailed organization analyses for the projected period. (digitaljournal.com)
  • Cancer Nanomedicine Market to Build Excessive Revenue at. (pharmiweb.com)
  • The report is a wide-ranging source of widespread facts and figures for business strategists as it offers the historical &futuristic data such as demand & supply data, cost, revenue, profit, supply chain value, and so on. (pharmiweb.com)
  • Increase in prevalence of chronic ailments such as liver cirrhosis, cardiovascular diseases, cancer, and others is another factor driving revenue of the nanopharmaceutical drugs market. (emergenresearch.com)
  • Increasing Research & Development (R&D) for development of nanorobots to treat cancer and thrombotic diseases is also driving market revenue growth. (emergenresearch.com)
  • Increasing funding from government and non-government organizations in nanomedical research is a significant factor driving revenue of the nanopharmaceutical drugs market. (emergenresearch.com)
  • Increase in integration of nanoparticles in drug discovery is a major factor driving revenue of this segment. (emergenresearch.com)
  • Brand-name drugs remain the key driver of wholesalers' revenue growth. (drugchannels.net)
  • COVID-19 had significantly benefited the market in terms of adoption and revenue growth. (marketresearch.com)
  • In addition, it is used to deliver drugs or vaccines painlessly, as they do not activate the nerve endings that are responsible for pain. (grandviewresearch.com)
  • U.S. sales of drugs to treat impotence have leveled off at about $1 billion a year, despite heavy advertising on televised sports events and other promotional campaigns. (latimes.com)
  • We project that in 2016, for the first time, the Big Three wholesalers' combined drug distribution revenues will exceed $400 billion. (drugchannels.net)
  • The market was valued at USD 1.20 billion in 2021, and it would grow upto USD 2.0 billion by 2029. (databridgemarketresearch.com)
  • Drug companies spend $15 billion on marketing and rake in $200 billion in sales a year in this county. (psychrights.org)
  • In addition to this, the report also provides the SWOT analysis for Concerta and emerging therapies in this space. (valuates.com)
  • We also provide detailed information on the regulatory environment and the role of disruptive technology in the medical devices industry, so you can stay ahead of the newest developments. (marketresearch.com)
  • Owing to the increase in the obesity population worldwide, the key players in the market are initiating product developments and seeking market approvals. (mordorintelligence.com)
  • The first, focused on the past twenty-five years of drug surveillance, provides a history of key developments in the monitoring and reporting of adverse drug reactions, emphasizing lessons learned from different national and international systems for collecting, interpreting, and communicating data. (who.int)
  • Novartis, for instance, recently sold a generics division run by Sandoz so Sandoz could focus on other drugs, including biosimilars, which compete with expensive biologic drugs made from living organisms. (californiahealthline.org)
  • According to the World Health Organization's report published in June 2021, 39 million children under the age of 5 years were overweight or obese in 2020. (mordorintelligence.com)
  • The conference, which marked the 25th anniversary of the World Health Organization's programme for international drug monitoring, also responded to a number of new challenges created by the use of biotechnology to develop novel products, and the recently discovered importance of genetically determined differences in drug metabolism. (who.int)
  • Organized for the 25th anniversary of the World Health Organization's Programme for International Drug Monitoring. (who.int)
  • Competitive analysis of the industry players along with the overview on strategic management. (medgadget.com)
  • The Trump administration has been trumpeting a huge increase in FDA generic drug approvals the past two years, the result of its actions to streamline a cumbersome process and combat anti-competitive practices. (californiahealthline.org)
  • The report presents the market competitive landscape and a consistent in depth analysis of the major vendor/key players in the market. (openpr.com)
  • The competitive landscape of the market has been elaborated by studying a number of factors such as the best manufacturers, prices and revenues. (openpr.com)
  • The research information and studies associated with participant analysis keep the competitive landscape noticeably into the focus with which the market can select or advance their own policies to increase in the market growth. (marketresearchupdate.com)
  • Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. (strategyr.com)
  • This helps the reader to determine the competitive strength of the market and to make informed decisions. (stockmarketmonster.com)
  • The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. (prnewswire.com)
  • See Latest CMS Forecast Shows Big Drug Spending Growth Through 2025 . (drugchannels.net)
  • It provides information on the fundamental business strategies used in this market. (menafn.com)
  • In 2021, the market is growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon. (menafn.com)
  • What are the popular business strategies being used by in silico drug discovery service providers? (ipsnews.net)
  • Such networks dominate Medicare Part D prescription drug plans and are a crucial element of payers' specialty drug management strategies. (drugchannels.net)
  • The report also offers a detailed investigation of key market players and their strategies, such as new product launches, expansions, and mergers. (stockmarketmonster.com)
  • Also, the presence of raw material in the developing regions such as Asia and LAMEA, provides lucrative opportunities for the market players to invest in this region. (researchandmarkets.com)
  • Key areas of investments identifying market opportunities and challenges in forecast timeframe. (medgadget.com)
  • The increasing number of road accidents in the region will create growth opportunities for the market as FM can occur to people involved in road accidents, thereby boosting the market expansion in the region. (giiresearch.com)
  • Our reports help you gauge the pulse of the market, identify key growth opportunities, and make informed business decisions. (marketresearch.com)
  • The growing usages of nanomedicine in drug delivery technology will further create various opportunities for the growth of the market. (pharmiweb.com)
  • Prescription drug access and affordability-along with new challenges and opportunities-will continue to be issues for state leaders to consider. (ncsl.org)
  • Basis on product type it covers BP monitoring devices, pulmonary pressure monitoring devices and ICP monitoring devices. (openpr.com)
  • To define, describe and forecast the market by product type, market and key regions. (medgadget.com)
  • Pricing analysis is covered in this report according to each type, manufacturer, regional analysis, and price. (digitaljournal.com)
  • In addition, research on several potential drug molecules that target both obesity and Type 2 diabetes mellitus has become a key trend among the anti-obesity market players. (mordorintelligence.com)
  • The increasing epidemic of obesity and Type 2 diabetes is encouraging researchers and vendors in the market to research drugs that can counter both obesity and Type 2 diabetes. (mordorintelligence.com)
  • Further, it includes the all-inclusive comprehension of several factors such as drivers, constraints, and major micro markets. (pharmiweb.com)
  • For instance, in January 2021, Novartis AG announced the results of its Phase II trial of the investigational product drug called Bimagrumab. (mordorintelligence.com)
  • In addition, acquisition and partnerships by the key market players are the boosting factors for the market. (researchandmarkets.com)
  • Key players are involved in mergers and acquisition to strengthen their market position. (medgadget.com)
  • 2.How do you determine the list of the key players included in the report? (menafn.com)
  • Market experts have also described all the major players in the Clinical Trial Kits Market, taking into account key aspects such as area of operation, production, and product portfolio. (newstechzone.com)
  • Top players and types are taking actions alongside inclinations, stock dispatches, acquisitions, consolidations, joint endeavors, and forceful research inside the IBS-C Drugs market. (marketresearchupdate.com)
  • Major players in the contract research and manufacturing services (CRAMS) market are Boehringer Ingelheim International GmbH, Catalent Inc., Lonza Group Ltd., Pharmaceutical Product Development LLC, Baxter BioPharma Solutions, AbbVie, Grifols International S.A., and Dalton Pharma Services . (thebusinessresearchcompany.com)
  • Microneedle drug delivery systems are more beneficial than conventional hypodermal injections, because of advantages such as the quicker onset of action, increased permeability and efficacy, better patient compliance, and self-administration. (grandviewresearch.com)
  • In addition, microneedle drug delivery systems have the potential to increase drug efficacy by improving drug absorption and targeting specific areas of the body. (grandviewresearch.com)
  • Generally, the cost of generic drugs is 50-70 percent lower than that of their brand-name counterparts, while meeting the very same standards of safety, quality, and efficacy as the innovator drugs. (clickpress.com)
  • Research services outsourcing of research services such as clinical trial data management, database design and build, data entry and validation, medicine and disease coding, project management, quality, and metric reporting, safety and efficacy summaries, statistical analysis plans and reports, on a contract basis. (thebusinessresearchcompany.com)
  • However, the pandemic has slowed down clinical trials of microneedle drug delivery systems. (grandviewresearch.com)
  • The most important advantage of generic drugs is they are less expensive as compared to branded drugs because they are not required to repeat costly clinical trials and pay for marketing, advertising and for promotion. (globenewswire.com)
  • Drug Delivery technologies modify drug publication profile, preoccupation, supply and removal for the profit of improving product effectiveness and safety, as well as patient suitability and obedience. (medgadget.com)
  • Drug manufacturers with a risk for benzene contamination should test their drugs accordingly and should not release any drug product batch that contains benzene above 2 ppm, consistent with the recommendations described in the ICH Q3C guidance. (fda.gov)
  • If any drug product batches with benzene above 2 ppm are already in distribution, the manufacturer should contact FDA to discuss the voluntary initiation of a recall by contacting the appropriate Division of Pharmaceutical Quality Operations in the Office of Regulatory Affairs . (fda.gov)
  • Risks of negative effects from misuse of the product can be a limitation of the dermatology drugs market. (resourcekt.co.uk)
  • Another issue hampering the growth of the market is the negative product-related effects. (resourcekt.co.uk)
  • This is expected to reduce product adoption, leading to a decline in the market value of dermatological drugs. (resourcekt.co.uk)
  • Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. (strategyr.com)
  • A) The research would help top administration/policymakers/professionals/product advancements/sales managers and stakeholders in this market in the following ways. (stockmarketmonster.com)
  • One example was "Project SCUM" (Sub-Culture Urban Marketing), a 1990's marketing strategy that attempted to co-brand tobacco as part of drug culture through product placement in shops that sold related paraphernalia. (cdc.gov)
  • To help protect people with behavioral health conditions from tobacco marketing and discourage tobacco use, states and communities could consider increasing prices and prohibiting price discounts, prohibiting the sale of flavored tobacco products, and either allowing fewer stores in a neighborhood to sell commercial tobacco products or prohibiting tobacco product sales altogether. (cdc.gov)
  • This product is primarily marketed as a dietary supplement to promote weight loss and to raise the body's metabolic rate. (nih.gov)
  • Of these, 6 Adverse Event Reports where clinically confirmed from the product label as associated with LipoKinetix/Sodium Usniate , including one case of liver failure, 3 cases of chemical hepatitis, and two cases of mild hepatic toxicity. (nih.gov)
  • A Medwatch report dated 1/15/2003 reported the need for a liver transplant in a 28 year old healthy female who developed fulminant liver failure after approximately two weeks of using a product with Pure Usnic Acid taken per the label's recommended dosing. (nih.gov)
  • The report covers the market landscape of the Generic Drugs market in Japan and its growth prospects over the coming years. (clickpress.com)
  • This includes Investigation of past progress, ongoing market scenarios, and future prospects. (openpr.com)
  • The pharmaceutical industry's revenues will continue to shift from traditional brand-name drugs to specialty drugs. (drugchannels.net)
  • Republican Gov. Larry Hogan wrote last year that he shared the drug industry's concerns about the law and let it go into effect without signing it. (healthcareforall.com)
  • Consolidation on multiple tiers of the drug supply chain have changed the face of the generic drug market, warping supply and demand. (californiahealthline.org)
  • A generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded drugs. (clickpress.com)
  • The market for the generic drug has been accelerated by increasing number of patent expiration of branded drugs and government initiatives. (globenewswire.com)
  • In addition, prescription of doctors is largely affecting the growth of generic drug market because doctors are prescribing branded drugs to their patient. (globenewswire.com)
  • Based on the brand classification, generic drug market is segmented as pure generic and branded generic. (globenewswire.com)
  • Generic inflation began easing in 2015, due partly to the FDA having cleared much of the backlog for new generic drug applications. (drugchannels.net)
  • Wynn wrote that their ruling would stop "Maryland from protecting its citizens against unconscionable pricing practices by out-of-state generic drug manufacturers. (healthcareforall.com)
  • Companies that engage in off-label promotion should be heavily fined and their future marketing practices subject to increased scrutiny by regulatory agencies. (medscape.com)
  • Papers in the econd part, on methodological approaches, describe and compare various mechanisms for supervising drugs on the market and alerting regulatory authorities and prescribers to adverse reactions. (who.int)
  • Companies must seek a waiver to submit safety reports in the ICH Periodic Benefit-Risk Evaluation Report format instead of the FDA's format. (fdanews.com)
  • The agency recommends this process if companies must submit safety reports to multiple international authorities, including the European Union and Japan. (fdanews.com)
  • In recent years, vast industry consolidation has reduced the ranks of companies willing to purchase and distribute generics. (californiahealthline.org)
  • Erin Fox, a pharmacist at the University of Utah who tracks drug shortages, said the KHN analysis of stalled generics "highlights that companies often have a lot of products 'on the books' but aren't really making them. (californiahealthline.org)
  • This study explores the market of health programs that help companies to augment productivity and to simultaneously reduce overall operational costs. (bccresearch.com)
  • We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. (strategyr.com)
  • several companies have developed novel tools, which are specifically designed to accelerate and augment the drug discovery process. (ipsnews.net)
  • Around 90 companies are currently providing software tools, web applications and other technology platforms for drug discovery. (ipsnews.net)
  • On the other hand, there are companies that are using this approach for drug discovery operations, in emerging regions, such as India and China, as well. (ipsnews.net)
  • Corporate Benchmarks/KPI Reports Available on 4,000 Different U.S. Public Companies - Benchmarked Against their Industry Peers. (plunkettresearch.com)
  • Manufacturing services include outsourcing drug development services to companies operating in the pharmaceutical or biotechnology industry on a contract basis. (thebusinessresearchcompany.com)
  • Tobacco companies have created marketing plans that target population groups, including people who use illicit substances. (cdc.gov)
  • Tobacco companies spend billions of dollars each year to aggressively market their products. (cdc.gov)
  • Tobacco companies market and advertise tobacco products to people with behavioral health conditions. (cdc.gov)
  • But more than 700, or about 43 percent, of those generics still weren't on the market as of early January, a KHN data analysis of FDA and drug list price records shows. (californiahealthline.org)
  • With our vast collection of research, you can quickly access hard-to-find data on industries big and small. (marketresearch.com)
  • When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year. (strategyr.com)
  • Use MarketGlass TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports. (strategyr.com)
  • The purpose of this report is to provide vital financial data, benchmarking, and financial analysis for the corporation of your choice. (plunkettresearch.com)
  • FYI: I updated a few links with our more current market data. (drugchannels.net)
  • The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight`s team of industry experts. (valuates.com)
  • Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases. (valuates.com)
  • Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. (prnewswire.com)
  • Reportlinker reviews, finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. (prnewswire.com)
  • Papers from the final session explore the many practical, legal, and ethical issues surrounding access to information and the decision to release data about drug risks to patients and the public. (who.int)
  • Based on Distribution Channel, the market is segmented into Drug stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. (giiresearch.com)